ZYLASTXP ANTISEPTIC- benzethonium chloride lotion

ZylastXP Antiseptic by

Drug Labeling and Warnings

ZylastXP Antiseptic by is a Otc medication manufactured, distributed, or labeled by Innovative BioDefense. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

ACTIVE INGREDIENT

Benzethonium Chloride - 0.2%

PURPOSE

Antiseptic

ASK DOCTOR

Discontinue use of irritation and redness develops. Consult a doctor if condition persists for more than 72 hours.

DOSAGE & ADMINISTRATION

Wet hands thoroughly with product and allow to dry without wiping.

WARNINGS

For external use only. Avoid contact with eyes. In case of eye contact, rinse eyes thoroughly with water. Discontinue use if irritation and redness develops. Consult a doctor if condition persists for more than 72 hours. If swallowed, immediately call Poison Control Center or doctor.

INACTIVE INGREDIENT

Water, Alcohol Denat., Cetearyl Alcohol, Glycerin, Polyaminopropyl Biguanide, Dimethicone, Stearamidopropyl Dimethylamine, Benzyl Alcohol, Farnesol, Panthenol, Zinc Gluconate, Chlorhexidine Digluconate, Citric Acid, Polyquaternium-10, Tocopheryl Acetate.

INDICATIONS & USAGE

Handwash to decrease bacteria on the skin that potentially can cause disease. Recommended for repeated use.

KEEP OUT OF REACH OF CHILDREN

If swallowed, immediately call Poison Control Center or doctor.

PRINCIPAL DISPLAY PANEL

NDC: 57362-464-03

ZylastXP Antiseptic Lotion 8oz

Broad Spectrum

Antimicrobial

Fast Acting

-front-

-back-

INGREDIENTS AND APPEARANCE

ZYLASTXP ANTISEPTIC 
benzethonium chloride lotion

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 57362-464
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
BENZETHONIUM CHLORIDE (UNII: PH41D05744) (BENZETHONIUM - UNII:1VU15B70BP)	BENZETHONIUM CHLORIDE	192.3 mg  in 1000 mg

Inactive Ingredients
Ingredient Name	Strength
WATER (UNII: 059QF0KO0R)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 57362-464-03	227 mg in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product	01/15/2019

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC monograph not final	part333E	04/24/2015

Labeler - Innovative BioDefense (078363903)